Pharmaceutical Business review

UK court uphelds two KCI patents validity

The Court also found that NPWT products marketed by Smith & Nephew (SNN) infringe one of the patents.

In June 2010, the High Court of Justice Chancery Division, Patents Court found that SNN’s Renasys NPWT products infringe valid claims of two KCI patents.

The company said that the current ruling upholds the High Court’s ruling as it related to infringement of an important claim of European Patent No 0853950.

KCI Active Healing Solutions business global president Mike Genau said that this is not just a victory for KCI, it is also a victory for patients and the health care community that benefit from safe, clinically proven products.

"Patient outcomes and safety remain our primary focus and we’re committed to helping our UK customers immediately transition from infringing products to VAC Therapy," Genau said.